ING Groep NV Lowers Position in McKesson Co. (NYSE:MCK)

ING Groep NV lowered its position in McKesson Co. (NYSE:MCK - Free Report) by 1.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 100,163 shares of the company's stock after selling 1,830 shares during the quarter. ING Groep NV owned approximately 0.08% of McKesson worth $57,084,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Sequoia Financial Advisors LLC boosted its holdings in McKesson by 3.5% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 6,594 shares of the company's stock valued at $3,260,000 after acquiring an additional 226 shares during the period. Eastern Bank bought a new stake in McKesson during the 3rd quarter valued at $258,000. Waldron Private Wealth LLC boosted its position in McKesson by 45.3% during the 3rd quarter. Waldron Private Wealth LLC now owns 1,335 shares of the company's stock valued at $661,000 after buying an additional 416 shares during the period. Stanley Laman Group Ltd. grew its holdings in McKesson by 2.6% in the 3rd quarter. Stanley Laman Group Ltd. now owns 9,636 shares of the company's stock worth $4,764,000 after acquiring an additional 244 shares during the last quarter. Finally, Lecap Asset Management Ltd. purchased a new position in shares of McKesson in the third quarter valued at about $1,583,000. Hedge funds and other institutional investors own 85.07% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on MCK. Baird R W raised McKesson from a "hold" rating to a "strong-buy" rating in a research note on Thursday, November 7th. Bank of America cut their price objective on McKesson from $680.00 to $650.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Morgan Stanley upped their target price on McKesson from $612.00 to $642.00 and gave the company an "overweight" rating in a report on Tuesday, December 17th. Mizuho began coverage on shares of McKesson in a research report on Wednesday, December 4th. They set a "neutral" rating and a $630.00 price objective on the stock. Finally, StockNews.com lowered shares of McKesson from a "strong-buy" rating to a "buy" rating in a report on Friday, February 14th. Two analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $645.79.

McKesson Stock Down 1.0 %

Shares of MCK stock traded down $5.83 during trading hours on Friday, hitting $597.68. 671,026 shares of the company's stock traded hands, compared to its average volume of 745,545. The stock has a market cap of $74.91 billion, a price-to-earnings ratio of 27.37, a PEG ratio of 1.29 and a beta of 0.52. The stock's fifty day simple moving average is $588.60 and its two-hundred day simple moving average is $562.48. McKesson Co. has a 12-month low of $464.42 and a 12-month high of $637.51.

McKesson (NYSE:MCK - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $8.03 EPS for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. On average, equities analysts forecast that McKesson Co. will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Monday, March 3rd will be given a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 0.48%. The ex-dividend date is Monday, March 3rd. McKesson's dividend payout ratio (DPR) is 13.00%.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Leann B. Smith sold 579 shares of the company's stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total transaction of $331,645.41. Following the transaction, the executive vice president now owns 864 shares in the company, valued at approximately $494,890.56. This represents a 40.12 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Brian S. Tyler sold 8,961 shares of the firm's stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $600.66, for a total transaction of $5,382,514.26. Following the completion of the sale, the chief executive officer now owns 69,625 shares in the company, valued at $41,820,952.50. This represents a 11.40 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 10,307 shares of company stock worth $6,177,790. 0.11% of the stock is owned by corporate insiders.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.